Utilisation of blood glucose test strips in insulin-requiring people with diabetes mellitus using continuous glucose monitoring in Saxony-Anhalt – Analysis of health insurance data

IF 6.1 3区医学 Q1 ENDOCRINOLOGY & METABOLISM

Diabetes research and clinical practice Pub Date : 2024-12-01 DOI:10.1016/j.diabres.2024.111935

Sara Lena Lückmann , Antonia Förster , Stephanie Heinrich , Christian Buhtz , Gabriele Meyer , Rafael Mikolajczyk , Steffen Fleischer

{"title":"Utilisation of blood glucose test strips in insulin-requiring people with diabetes mellitus using continuous glucose monitoring in Saxony-Anhalt – Analysis of health insurance data","authors":"Sara Lena Lückmann , Antonia Förster , Stephanie Heinrich , Christian Buhtz , Gabriele Meyer , Rafael Mikolajczyk , Steffen Fleischer","doi":"10.1016/j.diabres.2024.111935","DOIUrl":null,"url":null,"abstract":"<div><h3>Aims</h3><div>Continuous glucose measurement (CGM) systems are increasingly utilised by people with diabetes mellitus (DM) and less is known about usage behaviour. Therefore, this study aims to analyse additionally utilisation of blood glucose measurement (BGM) for insurants who are using CGM.</div></div><div><h3>Methods</h3><div>The study used secondary data, health claims data from the AOK Saxony-Anhalt (Germany), from 2016 to 2021, analysing a sample of 52,296 individuals with insulin-requiring DM.</div></div><div><h3>Results</h3><div>Nearly all CGM users reduced their utilisation of BGM test strips. 2,306 persons with CGM long-time utilisation, about half showed a mean usage behaviour, nearly one third did not use test strips anymore, about 8 % stopped using CGM, 9 % were intense users. A high test strip utilisation beside CGM was associated with younger age, T1DM, a high number of test strip before starting CGM, no contact with a general practitioner, and no enrolment in a disease management program.</div></div><div><h3>Conclusions</h3><div>Great differences in reductions and usage behaviour was revealed between insurants. The results can be used to better identify and offer more tailored CGM to people with DM, and to better tailor CGM trainings.</div></div>","PeriodicalId":11249,"journal":{"name":"Diabetes research and clinical practice","volume":"218 ","pages":"Article 111935"},"PeriodicalIF":6.1000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes research and clinical practice","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0168822724008453","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

Abstract

Aims

Continuous glucose measurement (CGM) systems are increasingly utilised by people with diabetes mellitus (DM) and less is known about usage behaviour. Therefore, this study aims to analyse additionally utilisation of blood glucose measurement (BGM) for insurants who are using CGM.

Methods

The study used secondary data, health claims data from the AOK Saxony-Anhalt (Germany), from 2016 to 2021, analysing a sample of 52,296 individuals with insulin-requiring DM.

Results

Nearly all CGM users reduced their utilisation of BGM test strips. 2,306 persons with CGM long-time utilisation, about half showed a mean usage behaviour, nearly one third did not use test strips anymore, about 8 % stopped using CGM, 9 % were intense users. A high test strip utilisation beside CGM was associated with younger age, T1DM, a high number of test strip before starting CGM, no contact with a general practitioner, and no enrolment in a disease management program.

Conclusions

Great differences in reductions and usage behaviour was revealed between insurants. The results can be used to better identify and offer more tailored CGM to people with DM, and to better tailor CGM trainings.

查看原文本刊更多论文

萨克森-安哈尔特州使用连续血糖监测的糖尿病患者对胰岛素需求者血糖试纸的使用情况--医疗保险数据分析。

目的：糖尿病（DM）患者越来越多地使用连续血糖测量（CGM）系统，但对其使用行为的了解却较少。因此，本研究旨在对使用 CGM 的投保人额外使用血糖测量系统（BGM）的情况进行分析：研究使用了二级数据，即 AOK Saxony-Anhalt（德国）从 2016 年至 2021 年的健康理赔数据，分析了 52,296 名需要使用胰岛素的 DM 患者：几乎所有 CGM 用户都减少了血糖仪试纸的使用量。2306名长期使用CGM的患者中，约一半表现出平均使用行为，近三分之一不再使用试纸，约8%停止使用CGM，9%为高强度使用者。在使用 CGM 的同时大量使用试纸与年龄较小、T1DM、开始使用 CGM 前试纸数量较多、未与全科医生联系以及未参加疾病管理计划有关：不同投保人在减免和使用行为方面存在巨大差异。这些结果可用于更好地识别糖尿病患者，为他们提供更有针对性的 CGM，以及更好地定制 CGM 培训。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Diabetes research and clinical practice 医学-内分泌学与代谢

CiteScore

10.30

自引率

3.90%

发文量

862

审稿时长

32 days

期刊介绍： Diabetes Research and Clinical Practice is an international journal for health-care providers and clinically oriented researchers that publishes high-quality original research articles and expert reviews in diabetes and related areas. The role of the journal is to provide a venue for dissemination of knowledge and discussion of topics related to diabetes clinical research and patient care. Topics of focus include translational science, genetics, immunology, nutrition, psychosocial research, epidemiology, prevention, socio-economic research, complications, new treatments, technologies and therapy.